Western blot analysis of extracts from NIH/3T3 cells, untreated or treated with calyculin A #9902 (50 nM) for 10 minutes, using Phospho-NF-κB p65 (Ser276) Antibody (upper) or NF-κB p65 Antibody #3034 (lower).
Immunohistochemical analysis of paraffin-embedded human breast carcinoma using Phospho-NF-κB p65 (Ser 276) Antibody in the presence of control peptide (left) or Phospho-NF-κB p65 (Ser276) Blocking Peptide #1437 (right).
Immunohistochemical analysis of paraffin-embedded human breast carcinoma, untreated (left) or Calf Intestinal Phosphatase (CIP) treated (right), using Phospho-NF-kappaB p65 (Ser276) Antibody.
Immunohistochemical analysis of paraffin-embedded human breast carcinoma using Phospho-NF-κB p65 (Ser276) Antibody.
Immunohistochemical analysisof paraffin-embedded human colon carcinoma using Phospho-NF-kappaB p65 (Ser276) Antibody.
Immunohistochemical analysisof paraffin-embedded human lung carcinoma, showing nuclear localization, using Phospho-NF-κB p65 (Ser276) Antibody.
Immunohistochemical analysis of paraffin-embedded PC-3 cells using Phospho-NF-κB p65 (Ser276) Antibody.
Immunohistochemical analysis of paraffin-embedded human lung carcinoma, using Phospho-NF-κB p65 (Ser276) Antibody in the presence of control peptide (left) or Phospho-NF-κB p65 (Ser276) Blocking Peptide #1437 (right).